Anticytokine therapy in autoimmune diseases.
暂无分享,去创建一个
[1] G. Firestein,et al. Anticytokine therapy in rheumatoid arthritis. , 1997, The New England journal of medicine.
[2] T. Kishimoto,et al. Plasma cell dyscrasias. , 1997, Advances in immunology.
[3] R. Zinkernagel,et al. Immunopathology or Organ‐Specific Autoimmunity as a Consequence of Virus Infection , 1996, Immunological reviews.
[4] Y. Shima,et al. Oncostatin M, leukemia inhibitory factor, and interleukin 6 induce the proliferation of human plasmacytoma cells via the common signal transducer, gp130 , 1994, The Journal of experimental medicine.
[5] B. Klein,et al. Brief report: alleviation of systemic manifestations of Castleman's disease by monoclonal anti-interleukin-6 antibody. , 1994, The New England journal of medicine.
[6] N. Udagawa,et al. Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[7] J. Saldanha,et al. Reshaping a human antibody to inhibit the interleukin 6-dependent tumor cell growth. , 1993, Cancer research.
[8] D. Wendling,et al. Treatment of severe rheumatoid arthritis by anti-interleukin 6 monoclonal antibody. , 1993, The Journal of rheumatology.
[9] T. Kishimoto,et al. Interleukin-6 in autoimmune disorders. , 1992, Seminars in immunology.
[10] M. Jourdan,et al. Murine anti-interleukin-6 monoclonal antibody therapy for a patient with plasma cell leukemia. , 1991, Blood.
[11] H. Mcdevitt,et al. Antigen Recognition and Peptide‐Mediated Immunotherapy in Autoimmune Disease , 1990, Immunological reviews.
[12] K. Matsumoto,et al. Interleukin 6 and expression of its receptor on epidermal keratinocytes. , 1990, Cytokine.
[13] A. Muraguchi,et al. Involvement of IL-6 in mesangial proliferative glomerulonephritis. , 1989, Journal of immunology.
[14] T. Komori,et al. Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease , 1989 .
[15] T. Hirano,et al. Interleukin-6 is a potent thrombopoietic factor in vivo in mice. , 1989, Blood.
[16] T. Kishimoto,et al. The biology of interleukin-6. , 1989, Blood.
[17] T. Ulich,et al. In vivo hematologic effects of recombinant interleukin-6 on hematopoiesis and circulating numbers of RBCs and WBCs. , 1989, Blood.
[18] T. Hirano,et al. IL-6/BSF-2 functions as a killer helper factor in the in vitro induction of cytotoxic T cells. , 1988, Journal of immunology.
[19] A. Okano,et al. Synergism of BSF-2/interleukin 6 and interleukin 3 on development of multipotential hemopoietic progenitors in serum-free culture , 1988, The Journal of experimental medicine.
[20] Toshio Hirano,et al. Recombinant human interleukin‐6 (IL‐6/BSF‐2/HSF) regulates the synthesis of acute phase proteins in human hepatocytes , 1988, FEBS letters.
[21] P. Lansdorp,et al. Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[22] T. Hirano,et al. Recombinant human B cell stimulatory factor 2 (BSF‐2/IFN‐β2) regulates β‐fibrinogen and albumin mRNA levels in Fao‐9 cells , 1987 .
[23] T. Hirano,et al. Enhancement of the interleukin 2 receptor expression on T cells by multiple B-lymphotropic lymphokines. , 1987, Immunology letters.
[24] T. Taniguchi,et al. Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin , 1986, Nature.
[25] N. Nicola,et al. Purification of a factor inducing differentiation in murine myelomonocytic leukemia cells. Identification as granulocyte colony-stimulating factor. , 1983, The Journal of biological chemistry.
[26] T. Kishimoto,et al. Induction of proliferation and Ig production in human B leukemic cells by anti-immunoglobulins and T cell factors. , 1982, Journal of immunology.
[27] T. Kishimoto,et al. T cell-replacing factor- (TRF) induced IgG secretion in a human B blastoid cell line and demonstration of acceptors for TRF. , 1981, Journal of immunology.
[28] B. Castleman,et al. Hyaline‐vascular and plasma‐cell types of giant lymph node hyperplasia of the mediastinum and other locations , 1972 .
[29] B. Castleman,et al. Localized mediastinal lymph‐node hyperplasia resembling thymoma , 1956, Cancer.